Perrigo (NYSE: PRGO) announced that it has received final Federal Drug Administration approval for Triamcinolone Acetonide Topical Aerosol, the generic ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE